News

Neurona Therapeutics Receives $3.8 Million CIRM Grant for the Development of Next Generation Neural Cell Therapy Candidate

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that the California Institute for Regenerative Medicine (CIRM) had awarded a $3.8M grant to support the development of a next-generation neural...

Venova Medical Announces $30 Million Series B Financing and Appointment of New Board Member

Venova Medical, Inc. (Venova Medical), a privately held company developing a next generation technology for the creation of percutaneous arteriovenous fistulas (pAVF) for hemodialysis access today announced the initial closing of a $30M Series B funding round.

ArsenalBio Announces $325 Million Financing to Advance Programmable Cell Therapy Programs through Clinical Development

Arsenal Biosciences, a clinical-stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, today announced the close of an oversubscribed $325 million Series C financing round. The funding round included new investors ARCH Venture Partners, Milky...

Biotechs take multiplexing into animal models to accelerate drug discovery

This April Gordian Biotechnology came out of stealth with $60 million in funding and a bold strategy for accelerating gene therapy to tackle aging. Gordian is dosing individual animals with many genetically labeled candidate therapies simultaneously, and then analyzing the distinctive impact of...

Shinobi Therapeutics Secures $59M Grant from the Japanese Agency for Medical Research and Development

Shinobi Therapeutics, the biotechnology company developing a new class of immune evasive iPS cell therapies, today announced that it has been awarded up to $59M in non-dilutive grant funding by the Japanese Agency for Medical Research and Development (AMED). The grant will be used to support the...

Bayer and Alara Imaging Announce Collaboration

Bayer has announced an exploratory collaboration with Alara Imaging at the annual AHRA (American Healthcare Radiology Administrators) conference. UCSF Innovation Ventures congratulates Rebecca Smith-Bindman, the lead UCSF inventor. MORE

The fifth annual pitch competition, Equalize Startups, turned 5 this year

On June 20th, Osage University, in partnership with Equalize Startups, celebrated the 5th annual pitch competition. Equalize Startups is dedicated to advancing female talent in academia-driven startups. The competition showcased remarkable innovators across Med Tech, Physical Sciences, Digital...

Montara Therapeutics Closes $8 Million Seed Round to Develop Safer, More Effective Neuroscience Drugs Using a Novel Brain-Only Pharmacology Approach

Montara Therapeutics, a therapeutics company aiming to revolutionize the discovery and development of brain-targeting drugs, announced today the closing of an oversubscribed $8 million seed financing led by SV Health Investors’ Dementia Discovery Fund and co-lead Two Bear Capital. Dolby Family...

Linus Health Acquires Together Senior Health to Expand its Platform to Better Serve Patients and Providers with End-to-end Workflow Capabilities

Linus Health, a digital health company enabling early detection of cognitive impairment, Alzheimer’s, and other dementias, today announced its acquisition of Together Senior Health (Together), a brain health company delivering evidence-based solutions for individuals with cognitive decline,...

Exai Bio Appoints New Chief Executive Officer

Exai Bio, a next-generation oncRNA- and generative AI-based liquid biopsy company, today announced the appointment of Dave Daly as Chief Executive Officer. With more than 30 years of cancer diagnostics and executive leadership experience, including at Thrive Earlier Detection (acquired by Exact...